ASML Stock: The Company That Makes the Machines That Make Every Advanced Chip on Earth

Situated halfway between Eindhoven and the Belgian border in the sleepy Dutch city of Veldhoven, which most people have never heard of, ASML Holding operates out of a campus that doesn’t appear to be the hub of anything particularly significant. There are security checkpoints, research facilities, and parking lots filled with the kind of sensible European vehicles used by engineers. Nevertheless, ASML constructs the machinery that makes it physically feasible to produce the most cutting-edge semiconductor chips in the world inside those facilities, in hygienic spaces with air quality standards that make hospital operating rooms seem informal. No other company in the world produces these state-of-the-art machines. That’s not language used in marketing. Because of this structural reality, ASML is now one of the most significant companies in the global technology supply chain and one of the more intriguing stocks to keep an eye on as 2026 becomes more complex.

The figures that characterize the company are truly remarkable. The yearly revenue is approximately $36.83 billion. $10.83 billion is the net profit. With a return on invested capital of 117.85 percent (not including cash and goodwill), ASML is virtually alone in the manufacturing of industrial equipment. Sales have increased at a 13% CAGR over the last five years. Over the same time period, EBIT increased by 22.77 percent, indicating that the company is not only growing in size but also increasing its profitability more quickly than its revenue. With a debt-to-free cash flow ratio of 0.25, ASML could use its current yearly cash generation to pay off all of its debt in roughly three months. These are the metrics that appear neatly on quality investing screens.

Nevertheless, there has been pressure on the stock. ASML underperformed even a declining technology sector, opening April 2 down 3.44 percent and briefly trading below the $1,300 mark on the Nasdaq. Mizuho downgraded the stock due to flat earnings per share projections and worries about sales trajectories in 2026. In late March, Barclays and Morgan Stanley took a cautious approach. The share price is currently below its 50-day moving average. This is the paradox at the core of the current ASML stock debate: analysts who are concerned about the short term are selling a company with exceptional fundamental qualities.

It’s important to comprehend the particular issues. ASML’s ability to sell its most cutting-edge EUV machines to China, a market that had been a significant source of revenue, has been hampered by Dutch export restrictions imposed under pressure from the United States. Helium, which ASML’s lithography machines need in large quantities for cooling systems, has caused supply chain anxiety due to the ongoing conflict in Iran. Workers at ASML’s Veldhoven headquarters went on strike on March 24 and 25, 2026, in protest of the company’s announced plan to eliminate about 1,700 jobs, mostly in technology and IT. This indicates that labor relations have become noticeably more complex. The company is hiring in both manufacturing and customer service at the same time, which suggests a true strategic reorientation rather than just cost-cutting. However, the management team obviously hadn’t anticipated the attention that a walkout at a company of this profile would garner.

The market is currently building toward the April 15 earnings date, with a particular focus: did Q1 revenue fall within the guidance range of €8.2 billion to €8.9 billion, how are deliveries of the new High-NA EUV EXE:5200 platform going, and can the company maintain gross margins in the management-targeted range of 51 to 53 percent? One of the biggest single orders in ASML’s history, the $8 billion order for EUV lithography systems from SK Hynix shows that demand at the top end of the product line is still high. ASML’s order book is directly impacted by memory chipmakers’ massive investments in next-generation production capacity.

It’s difficult to ignore the fact that, for a company of this caliber, the analyst community’s disagreement on ASML is remarkably broad. The high target is $1,971, while the consensus price target is around $1,475, suggesting significant upside from current levels. However, Mizuho and others anticipate a 2026 in which EUV shipment volumes may fall from 2025 highs and where China’s revenue loss is actual and hasn’t yet been entirely offset by other regions. There is internal consistency in both readings. JPMorgan is continuing to buy. Over the past year, the stock has nearly doubled. The bulls and bears are simply weighing near-term headwinds differently against a long-term structural position that appears to be virtually unassailable; neither is blatantly incorrect.

The EUV monopoly developed over decades of optical physics research, specialized supply chain partnerships with Carl Zeiss and Cymer, and institutional knowledge that cannot be swiftly replicated appear to be ASML’s primary competitive advantage. Going into April 15, the only question is whether the figures show that the short-term concerns are unfounded or if they warrant the cautious approach that some analysts have started to take.